Taysha Gene Therapies, Inc.'s revenue has grown 57% a year over three years. Revenue growth, 3-year annual rate: +57% (Biotechnology median +21%). Years of annual history on file: 6, FY2020 to FY2025, as filed.

TSHATaysha Gene Therapies, Inc.

Healthcare

$3.97-22% 1Y

$3.97

$3.5052 weeks$6.98

Is it growing?

Watch

Revenue shrinking (−32% year on year). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Revenue trend−32% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.